Drug shortage
Ifosfamide Injection · Baxter Healthcare
FDA drug shortage · Current · updated Oct 2, 2026
Key facts
| Generic name | Ifosfamide Injection |
|---|---|
| Company | Baxter Healthcare |
| Presentation | IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01) |
| Dosage form | Injection |
| Status | Current |
| Reason for shortage | Requirements related to complying with good manufacturing practices |
| Therapeutic category | Oncology Pediatric |
| Package NDCs | 0338-3993-01 |
| First posted | Jun 12, 2026 |
| Last updated | Oct 2, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: